Epocrates, Inc. Newsletters

Get the Most from Your PDA – Epocrates Webinars Show How

Check out the series of recent webinars that featured an emergency physician, family practitioner and a pediatrician sharing how to get the most from your Epocrates application. The series was recorded and is accessible via the web.

What can you get from these sessions? Well, how do you use your PDA? Sure, you use it for scheduling meetings and storing contact information, but is it helping you practice effectively when it matters most? These webinars focus on how to make sure you have the right mobile device and software to help you better meet the needs of your patients including:

Choosing the palmOne device that is right for you and determine how it can help you practice more efficiently

Learning how to use nearly all the functions in Epocrates Rx Pro and Epocrates Dx

Discovering the many ways you can use a palmOne with Epocrates software during every patient encounter

Keeping up with the latest in mobile mobile solutions for healthcare professionals

Simply go to: www.palmone.com/us/enterprise/news/webcastarchive.html
Once there, simply choose the Epocrates webinar you are interested in. The presenters were Marc Rucquoi, MD, The Family Healthcare Center, P.A. for the family practice session; Marc Lawrence, MD, Valley Medical Center, Level 1 Trauma Center and Seton Medical Center, Community Hospital for the emergency medicine session; and Chris Longhurst, MD, Stanford Children’s Hospital, for the pediatrics session.

BACK TO TOPICS >>

June 2004 - Issue No. 36


	This month's issue includes: Get the Most from Your PDA – Epocrates Webinars Show How New Bundle Brings Together Tungsten E + Epocrates Rx Pro and Epocrates Dx™ Built-In Dosing Calculator Easy to Find and Use Keep Your Clinical Information Current! AutoUpdate Now Epocrates User Recognized by Jed Foundation Epocrates Advocate of the Month – Dr. Kevin O’Neil

What's new this month at Epocrates

At Epocrates we want to ensure that our users are getting the most from our products. This month we are highlighting how to access our latest Epocrates MedTools™ software, as well as the dosing calculator embedded in the Epocrates Rx Pro™
drug reference. You can also check out the series
of recent informative webinars that featured an emergency physician, family practitioner and a pediatrician sharing how to get the most from your Epocrates® application. And for those of you who may be looking to upgrade your PDA or enhance your Epocrates experience through our suite, be
sure to take a look at our latest bundle.

Please read on to learn more. . .




		New Bundle Brings Together Tungsten E + Epocrates Rx Pro and Epocrates Dx™Along with the webinars, Epocrates has kicked off a new bundle which saves you up to $170 on a new palmOne Tungsten E, Tungsten T3 or Tungsten C mobile computer with the Epocrates Rx Pro and Epocrates Dx clinical references. This special offer is available through June 30th and includes a one-year subscription to the Epocrates Dx disease reference and a one-year subscription to the Epocrates Rx Pro clinical reference, a combined value of $120, and a palmOne Protection Plan Plus* (if you purchase a Tungsten T3 or Tungsten C. To learn more about this amazing bundle offer, click here. BACK TO TOPICS >>




	Built-In Dosing Calculator Easy to Find and Use One of the notable enhancements so far in 2004 to the Epocrates Rx Pro drug reference is the addition of the embedded dosing calculator. It’s easy to find and easy to use. It is accessible right from within the drug monograph. When you are looking at the dosing sections, if text is underlined, it links the dosing calculator. In general, users should make it a point to tap on underlined text within the Epocrates application because it typically links to other content and features or provides additional info in a pop-up. BACK TO TOPICS >>




	Keep Your Clinical Information Current! AutoUpdate Now One of the most important ways Epocrates contributes to enhancing patient safety is by providing reliable and up-to-date drug and clinical reference information. The Epocrates Medical Information Editors are regularly adding new drugs and updating content in the Epocrates Rx®, Epocrates Rx Pro™ and Epocrates Rx Online™ clinical references including new indications, FDA Medwatch changes, new drug-drug interactions and more. Please keep in mind that the list below highlights only key changes made to the clinical references. The Medical Information Editors are regularly updating the content. To keep your information current and reduce the risk of inadvertent medication errors, we recommend you AutoUpdate Epocrates Rx and Epocrates Rx Pro at least once per week. New FDA-approved prescription drugs Elestat - adult and pediatric allergic conjunctivitis Symbyax - depressive episodes of adult bipolar disorder New monographs for previously approved prescription drugs Delestrogen - hypoestrogenism, menopausal symptoms, palliative therapy in prostate CA Depo-Estradiol - hypoestrogenism, menopausal symptoms Gynodiol - hypoestrogenism, menopausal symptoms, osteoporosis prevention, palliative therapy in breast and prostate CA Panlor DC - adult pain Panlor SS - adult pain New Adult and Pediatric FDA approved indications for previously approved prescription drugs Cardizem LA - adult angina Cozaar - pediatric hypertension Lotensin - pediatric hypertension Vioxx - adult migraine headache MedWatch labeling change-related edits to previously approved prescription drugs Oxandrin - Drug Interaction: modification to statement involving warfarin interaction Zelnorm - Serious Reactions: severe diarrhea and ischemic colitis Status change for previously approved prescription drugs Aramine - brand discontinued Nasalide - brand discontinued Ogen Vaginal - brand discontinued Rhinocort - brand discontinued Suprax - now available in the US. Suprax trademark was purchased by Lupin Pharmaceuticals, Inc., who has FDA approval to market cefixime 400 mg tablets and 100 mg/5 ml oral suspension Teczem - brand discontinued Trilisate - brand discontinued Reformulation of OTC product Peri-Colace - from docusate/casanthranol to docusate sodium/senna In late 2002, the FDA ruled cascara sagrada to be either unsafe or ineffective for its intended use in OTC formulations. New Tables* (Epocrates Rx Pro users only) Discoloration, Feces Discoloration, Urine Have any questions? If you have any questions about AutoUpdate, please visit our support portal where you will find answers to the most commonly asked questions. You can also use the support portal to email our support team with specific questions. They will respond to your support request in the order in which it was received as quickly as possible. BACK TO TOPICS >>




	Epocrates User Recognized by Jed Foundation Kudos go out to Epocrates user David Brent, M.D., Academic Chief, Child and Adolescent Psychiatry, Western Psychiatric Institute and Clinic and Endowed Chair of Suicide Studies at the University of Pittsburgh School of Medicine, who is being honored June 7, at the Jed Foundation’s Third Annual Dinner and Awards Ceremony in New York City, for his contributions to reducing youth suicide. The Jed Foundation is a nonprofit public charity committed to reducing the youth suicide rate and improving the mental health safety net provided to college students nationwide. Phillip and Donna Satow started The Jed Foundation in 2000. The Satows lost their youngest son, Jed, 20, a university student, to suicide in 1998. The Satows have turned their personal tragedy into a nationwide effort to reprioritize mental health on college campuses and prevent suicide from affecting another family and campus community. Epocrates is showing its support of the Jed Foundation by participating in this annual event. Proceeds from the annual awards dinner assist the Foundation in continuing its lifesaving work, which in 2003 included providing an additional 1.7 million students at 300 colleges with free access to the Foundation’s Ulifeline.org website, leading the development of an important pilot suicide prevention program for college campuses, and initiating the first-ever National College Suicide Registry to accurately measure the severity of this problem. Even with the Foundation’s progress, it will continue to reach out to college students, as suicide remains the second leading cause of death for college students. Epocrates will be pursuing other ways to support the Foundation in 2004 including providing its Internet-based drug and clinical reference Epocrates Rx Online to campus health centers. For more information, visit www.jedfoundation.org. BACK TO TOPICS >>

-


	Epocrates Advocate of the Month – Dr. Kevin O’Neil Advocate of the Month This month we would like to thank Sarasota, Florida geriatrician Dr. Kevin O'Neil for his continued support of Epocrates over the years and for raising awareness about Epocrates products. Recently, Dr. O’Neil was featured in the New York Times regional newspaper article, “A dangerous mix: Combining drugs with certain foods or herbal supplements can be harmful to your health.” Here is an excerpt from the article. Dr. O’Neil admits that drug interactions were little understood when he was in medical school nearly 30 years ago. People were taking fewer vitamins and herbal supplements back then, too. But now he doesn’t take any chances. He uses a hand-held computer in his office to cross-reference drugs, foods and supplements to give his patients the latest information about things that could help or hurt them when they're on certain medications. “There's a wonderful program I use that I've recommended to other doctors. It's called Epocrates. It's not that expensive, maybe $50 a year, and I can download it into my Palm Pilot, which I can keep with me to do multiple checks on drugs and herbal supplements," O'Neil said. Advocate Program We created the Advocate Program for users who are interested in sharing information about Epocrates software with colleagues. For example, many Advocates demonstrate Epocrates software at medical society conferences and academic grand rounds. For more information on the Epocrates Advocate Program including how to join, please visit our website. BACK TO TOPICS >>

----00

This concludes the June issue of the Epocrates Newsletter.

Best wishes,

The Epocrates Team